Tilray | TRLY - 销售毛利

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.25B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	销售毛利	更改		日
Acasti Pharma	USD 75K		30K	2021-03
Akebia Therapeutics	USD 47.28M		1.7M	2025-12
Alaunos Therapeutics	USD -1.13M		1.11M	2024-09
Aurora Cannabis	CAD 46.62M		14.33M	2025-12
Avita Medical	AUD 14.31M		639K	2025-12
Canopy Growth	CAD 21.47M		434K	2025-12
Cronos Group	USD 16.19M		34.52M	2025-12
Dianthus Therapeutics	USD 284K		112K	2025-12
Divis Laboratories Ltd	INR 16.59B		2.05B	2025-12
Ionis Pharmaceuticals	USD 243M		48M	2026-03
IQVIA Holdings	USD 1.07B		52M	2026-03
Knight Therapeutics	CAD 64.72M		8.91M	2025-12
Moderna	USD -566M		792M	2026-03
Organigram Holdings	CAD 23.32M		8.52M	2025-12
Organon & Co	USD 854M		3M	2025-12
Revvity	USD 387.66M		34M	2026-03
Tectonic Therapeutic	USD 0		0	2025-03
Tilray	USD 57.47M		10.16M	2025-06
Viatris	USD 1.38B		229.9M	2026-03
Xeris Pharmaceuticals	USD 72.15M		8.77M	2025-12
Zealand Pharma A/S	68.91M		19.35M	2025-12